These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Factors associated with resistance to dementia despite high Alzheimer disease pathology. Fotuhi M; Hachinski V; Kivipelto M; Whitehouse P Neurology; 2009 Nov; 73(19):1607; author reply 1607-8. PubMed ID: 19901259 [No Abstract] [Full Text] [Related]
23. Can treatment with nonsteroidal anti-inflammatory drugs protect from dementia? Bregman N; Karni A; Korczyn AD Arch Neurol; 2009 Apr; 66(4):539-40; author reply 540. PubMed ID: 19364945 [No Abstract] [Full Text] [Related]
24. Folic acid and polyunsaturated fatty acids improve cognitive function and prevent depression, dementia, and Alzheimer's disease--but how and why? Das UN Prostaglandins Leukot Essent Fatty Acids; 2008 Jan; 78(1):11-9. PubMed ID: 18054217 [TBL] [Abstract][Full Text] [Related]
26. Do caregivers' experiences correspond with the concerns raised in the literature? Ethical issues relating to anti-dementia drugs. Huizing AR; Berghmans RL; Widdershoven GA; Verhey FR Int J Geriatr Psychiatry; 2006 Sep; 21(9):869-75. PubMed ID: 16955453 [TBL] [Abstract][Full Text] [Related]
27. [Dementia]. Sjöbeck M; Nilsson C Lakartidningen; 2009 May 13-19; 106(20):1369-73. PubMed ID: 19585832 [No Abstract] [Full Text] [Related]
28. [Cholinesterase inhibitors in dementia: the precarious balance between efficacy and safety]. Richard E; van Gool WA Ned Tijdschr Geneeskd; 2006 Mar; 150(10):530-2. PubMed ID: 16566413 [TBL] [Abstract][Full Text] [Related]
29. Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors. Liepelt I; Maetzler W; Blaicher HP; Gasser T; Berg D Dement Geriatr Cogn Disord; 2007; 23(6):351-67. PubMed ID: 17389795 [TBL] [Abstract][Full Text] [Related]
31. Rate of progression differs in frontotemporal dementia and Alzheimer disease. Kertesz A Neurology; 2006 May; 66(10):1607; author reply 1607. PubMed ID: 16717240 [No Abstract] [Full Text] [Related]
32. The case for alcohol in the primary prevention of dementia: abstinence may be bad for your health! Sherman FT Geriatrics; 2006 Aug; 61(8):10-2. PubMed ID: 16901191 [No Abstract] [Full Text] [Related]
33. Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing! Tabet N Age Ageing; 2006 Jul; 35(4):336-8. PubMed ID: 16788077 [TBL] [Abstract][Full Text] [Related]
34. Neuropsychiatric outcome for clinical trials. Robert P; Verhey FR; Aalten P; Cortes F; Byrne EJ J Nutr Health Aging; 2007; 11(4):345-7. PubMed ID: 17653496 [No Abstract] [Full Text] [Related]
35. Increased frontal phase-locking of event-related theta oscillations in Alzheimer patients treated with cholinesterase inhibitors. Yener GG; Güntekin B; Oniz A; Başar E Int J Psychophysiol; 2007 Apr; 64(1):46-52. PubMed ID: 17011650 [TBL] [Abstract][Full Text] [Related]
36. Alzheimer disease and its management: a review. Samanta MK; Wilson B; Santhi K; Kumar KP; Suresh B Am J Ther; 2006; 13(6):516-26. PubMed ID: 17122533 [TBL] [Abstract][Full Text] [Related]